Dr Reddys Laboratories Share Price Today - Live Blog for May 12, 2025

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.21% in its share price, and it currently trades at ₹1,192.65 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a -0.39% decrease, reaching a current market price of ₹1,193.05. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.9600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price rallied by 0.29%, reaching the current market price of ₹1,197.60. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd witnessed a -0.12% decrease in its share price, and it is currently trading at ₹1,194.05. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.9600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares experienced a -0.00% reduction, with the current market price at ₹1,194.95. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.11%, reaching the current market price of ₹1,195.00. This development underscores the stock's growing popularity.

The share price of Dr Reddys Laboratories Ltd plunged by -0.10%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,192.85, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.01%, signalling a challenging period. Currently trading at ₹1,192.85, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd remained stagnant, with no fluctuations. It is currently at ₹1,191.75. Investors may use this stability as an opportunity to reevaluate their portfolios and risk tolerance.

Dr Reddys Laboratories Ltd's stock has surged by 0.10%, and it is currently trading at ₹1,192.70. Additionally, the stock maintains a PE ratio of 17.9600, while the industry PE is 33.5236.

After a significant 0.24% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,191.30 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.05% boost, with the current market value at ₹1,189.55 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.53% uptick in its share price. As a result, it's now actively trading at ₹1,189.40 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd witnessed a -0.14% decrease in its share price, and it is currently trading at ₹1,185.35. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.9600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd plunged by -0.13%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,186.50, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd experienced a substantial 0.26% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,187.10, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.05% upswing, and it's currently trading at ₹1,186.00 per share. Investors are closely watching this development.

The stock of Dr Reddys Laboratories Ltd suffered a -0.11% drop, and it's now trading at ₹1,186.25 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd observed a -0.44% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,189.95. The stock has a PE ratio of 17.9600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced a -0.57% slump and is currently trading at ₹1,195.05. While the stock maintains a PE ratio of 17.9600, the industry PE is 33.5236, raising questions about valuation.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.12% increase and currently trading at ₹1,200.40 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd share price surged by 2.08%. With its current market price standing at ₹1,198.80 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's stock price surged by 0.00%, reaching the current market value of ₹1,165.85 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.18% upswing and is currently trading at ₹1,162.10, indicating strong market sentiment.

The stock of Dr Reddys Laboratories Ltd suffered a -0.46% decline, and it currently trades at ₹1,159.95 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.09% uptick in its share price. As a result, it's now actively trading at ₹1,166.00 per share, making it an attractive option for investors.